949095-98-1 Usage
Description
(RS)-4-(3-MethylaMino-1-thiophen-2-yl-propyl)-naphthalen-1-ol is a chiral organic compound with a complex structure, featuring a naphthalene core, a thiophenyl group, and a propyl chain with a methylamino substituent. Its stereochemistry is characterized by the presence of an (RS) configuration, indicating that it can exist as two enantiomers, which are mirror images of each other.
Uses
Used in Pharmaceutical Industry:
(RS)-4-(3-MethylaMino-1-thiophen-2-yl-propyl)-naphthalen-1-ol is used as an impurity in the synthesis of Duloxetine (D721000), an antidepressant medication and a dual serotonin and norepinephrine reuptake inhibitor (SNRI). Its presence is crucial for the development and quality control of Duloxetine, ensuring the purity and efficacy of the final product.
Used in Research and Development:
(RS)-4-(3-MethylaMino-1-thiophen-2-yl-propyl)-naphthalen-1-ol is also utilized in research settings to study its pharmacological properties and potential applications. Its unique structure and chiral nature make it an interesting subject for investigations into its interactions with biological systems and its potential therapeutic effects.
Used in Quality Control and Analysis:
(RS)-4-(3-MethylaMino-1-thiophen-2-yl-propyl)-naphthalen-1-ol serves as a reference standard in analytical methods for the quantification and identification of impurities in pharmaceutical products. Its use in high-performance liquid chromatography (HPLC) and other analytical techniques helps ensure the quality and safety of medications containing Duloxetine.
Check Digit Verification of cas no
The CAS Registry Mumber 949095-98-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,4,9,0,9 and 5 respectively; the second part has 2 digits, 9 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 949095-98:
(8*9)+(7*4)+(6*9)+(5*0)+(4*9)+(3*5)+(2*9)+(1*8)=231
231 % 10 = 1
So 949095-98-1 is a valid CAS Registry Number.
949095-98-1Relevant articles and documents
Process for the preparation of pure duloxetine hydrochloride
-
Page/Page column 4-5, (2009/10/18)
The present invention relates to a process for the preparation of pure Duloxetine hydrochloride. The present invention further relates to duloxetine hydrochloride substantially free of residual hydrochloric acid.
